- Home
- TBNK vs CLSD Comparison
TBNK vs CLSD Comparison
Compare TBNK & CLSD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TBNK
- CLSD
- Stock Information
- Founded
- TBNK 1921
- CLSD 2011
- Country
- TBNK United States
- CLSD United States
- Employees
- TBNK N/A
- CLSD N/A
- Industry
- TBNK Savings Institutions
- CLSD Biotechnology: Pharmaceutical Preparations
- Sector
- TBNK Finance
- CLSD Health Care
- Exchange
- TBNK Nasdaq
- CLSD Nasdaq
- Market Cap
- TBNK 70.7M
- CLSD 74.3M
- IPO Year
- TBNK N/A
- CLSD 2016
- Fundamental
- Price
- TBNK $8.98
- CLSD $0.93
- Analyst Decision
- TBNK Hold
- CLSD Strong Buy
- Analyst Count
- TBNK 2
- CLSD 6
- Target Price
- TBNK $9.89
- CLSD $5.33
- AVG Volume (30 Days)
- TBNK 24.8K
- CLSD 301.0K
- Earning Date
- TBNK 01-28-2025
- CLSD 03-11-2025
- Dividend Yield
- TBNK 0.45%
- CLSD N/A
- EPS Growth
- TBNK N/A
- CLSD N/A
- EPS
- TBNK N/A
- CLSD N/A
- Revenue
- TBNK $36,203,000.00
- CLSD $7,703,000.00
- Revenue This Year
- TBNK N/A
- CLSD N/A
- Revenue Next Year
- TBNK $8.07
- CLSD $91.87
- P/E Ratio
- TBNK N/A
- CLSD N/A
- Revenue Growth
- TBNK N/A
- CLSD 248.39
- 52 Week Low
- TBNK $6.92
- CLSD $0.80
- 52 Week High
- TBNK $11.60
- CLSD $2.12
- Technical
- Relative Strength Index (RSI)
- TBNK 31.86
- CLSD 42.76
- Support Level
- TBNK $8.96
- CLSD $0.90
- Resistance Level
- TBNK $9.39
- CLSD $0.97
- Average True Range (ATR)
- TBNK 0.25
- CLSD 0.05
- MACD
- TBNK -0.02
- CLSD 0.00
- Stochastic Oscillator
- TBNK 18.87
- CLSD 24.29
About TBNK Territorial Bancorp Inc.
Territorial Bancorp Inc operates as a bank holding company. It offers a wide variety of FDIC-insured deposit products and loan products for the consumer and small businesses. Its business consists of accepting deposits from the general public and investing those deposits, together with funds generated from operations and borrowings, in one-to-four-family residential mortgage loans and investment securities. The company offers a variety of deposit accounts, including passbook and statement savings accounts, certificates of deposit, money market accounts, commercial and regular checking accounts and Super NOW accounts Its loan segment portfolio consists of Residential Mortgage; Construction, Commercial, and Other Mortgage Loans; Home Equity loans & line of credit; and Consumer & others.
About CLSD Clearside Biomedical Inc.
Clearside Biomedical Inc is a United States-based clinical biopharmaceutical company. It is engaged in developing pharmacological therapies to treat blinding disease of the eye through the suprachoroidal space, or SCS. The company's novel SCS injection platform, utilizing proprietary SCS Microinjector, enables an in-office, repeatable, non-surgical procedure for the targeted and compartmentalized delivery of a wide variety of therapies to the macula, retina or choroid to potentially preserve and improve vision in patients with sight-threatening eye diseases.